ストックスクリーナーアプリを入手
0.428
0.94%
0.004
前日終値:
$0.424
開ける：
$0.4322
24時間の取引高:
208.77K
Relative Volume:
0.05
時価総額：
$6.96M
収益：
$72,100
当期純損益:
$-4.23M
株価収益率:
-0.7051
EPS:
-0.607
ネットキャッシュフロー:
$-4.66M
1週間 パフォーマンス:
+9.46%
1か月 パフォーマンス:
-4.76%
6か月 パフォーマンス:
-7.98%
1年 パフォーマンス:
-9.36%
1日の値動き範囲:
$0.4209
$0.4499
1週間の範囲:
$0.391
$0.4499
52週間の値動き範囲:
$0.221
$1.01
Silo Pharma Inc Stock (SILO) Company Profile
Compare SILO vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
3.5699 | 4.83B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.67 | 440.40M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.09 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.05 | 291.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.77 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc (SILO) 最新ニュース
Silo Pharma Inc. (SILO) Rallies 3.99% as Biotech Sentiment Improves — Key Levels in FocusHigh Yield Stocks - thelegaladvocate.com
Silo Pharma Inc. (SILO) Q4 2023 Earnings: Widening Losses as Pre-Revenue Biotech Focuses on Pipeline ProgressProfit Margin Analysis - Newser
SILO Q4 2023 Earnings: Biotech Misses EPS Estimates as Pre‑Revenue Phase ContinuesCrowd Stock Picks - Newser
SILO Stock Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma Inc. (SILO) Edges Higher as Shares Test Key ResistanceAggressive Growth Picks - Newser
Silo Pharma (SILO) Q4 2023 Results Disappoint: What Investors Should KnowRevenue Miss Report - thelegaladvocate.com
Silo Pharma (SILO) Q4 2023 Earnings: Miss Sparks ConcernTrending Entry Points - Newser
Silo Pharma (SILO) Stock Analysis: Falls -3.79%, Watching $0.35 2026-05-19NHNL Ratio - thelegaladvocate.com
Silo Pharma, Inc. (SILO) Q1 2026 10-Q: Financials, Crypto Asset Holdings, and Business Developments - Minichart
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Silo Pharma (NASDAQ: SILO) Q1 loss widens as R&D and crypto costs rise - Stock Titan
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative - citybuzz -
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Australia
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - ChartMill
Silo Pharma files patent for ibogaine-based therapy targeting traumatic brain injury. - Pluang
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
SILO Silo Pharma reports wider-than-expected Q4 2023 loss, shares dip 1.62% amid weak investor sentiment.High Attention Stocks - Newser
Silo Pharma’S Ptsd Program Advances As FDA Fast-Tracks Psychedelic Therapies For Ptsd - TradingView
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - GlobeNewswire
Washington speeds psychedelic PTSD work as Silo spotlights program - Stock Titan
Why did SILO stock soar 85% today? - MSN
Levi Strauss, Greenbrier and 3 stocks to watch heading into Tuesday - MSN
SILO Silo Pharma rises 5.57 percent despite reporting a wider than expected Q4 2023 per share loss.Gross Margin - Newser
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
SILO Price Today: Silo Pharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAxe Compute (NASDAQ:AGPU), Akanda (NASDAQ - Benzinga
Silo Pharma launches AI subsidiary, advances PTSD drug program By Investing.com - Investing.com India
AINewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expands Into AI With Qwikagents Asset Acquisition - FinancialContent
Silo Pharma Inc. posts 76.5% EPS miss with no reported revenueDividend Initiation - Cổng thông tin điện tử tỉnh Tây Ninh
Is Southern (SOJD) stock recovering momentum | Q3 2000: Profit SurprisesDecline Phase - Xã Thanh Hà
Silo Pharma launches AI subsidiary, advances PTSD drug program - Investing.com
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - The Manila Times
A biotech advancing a PTSD drug just bought an AI agent platform - Stock Titan
Silo Pharma, Inc. acquired Assets of Qwikagents.ai. - marketscreener.com
Silo Pharma highlights PTSD treatment program amid policy shift By Investing.com - Investing.com India
Silo Pharma highlights PTSD drug program amid policy shift By Investing.com - Investing.com India
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics - marketscreener.com
Silo Pharma (SILO) Stock Payout Ratio (Momentum Building) 2026-04-20Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
Silo Pharma highlights PTSD drug program amid policy shift - Investing.com
Silo Pharma highlights PTSD treatment program amid policy shift - Investing.com
Silo Pharma Positioned to Advance Treatment Targeting PTSD - GlobeNewswire
Silo Pharma Inc (SILO) 財務データ
収益
当期純利益
現金流量
EPS
Silo Pharma Inc (SILO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
0.37%
1.35%
大文字化:
|
ボリューム (24 時間):